Mortality Prediction For COVID-19 Patients Based on Demographic, Typical Laboratory Results, and Clinical Data


  • Husnul Khuluq Department Of Pharmacy, Faculty of Health Science, Universitas Muhammadiyah Gombong, 54413, Indonesia
  • Anwar Sodik Department Of Pharmacy, Faculty of Health Science, Universitas Muhammadiyah Gombong, 54413, Indonesia



death risk feature, hospital mortality prediction, comorbidities, bivariate analysis, prediction model


Background:Timely identification of patients with a high risk of mortality from COVID-19 can make a big improvement in triage, bed placement, time saving, and maybe even outcome . Objectives: construct and evaluate individual mortality risk estimates based on anonymised demographic, clinical, and laboratory data at admission, as well as to find out the probability of death Materials and methods: Data included 681 patients, obtained from two Muhammadiyah Hospitals in Kebumen, Central Java, Indonesia. Data was collected between January 2020 to December 2022. The medical records were examined to identify the demographic data, vital signs, clinical data and typical laboratory test. In bivariate analysis, the Chi-square test was used.. Results: Patients were 48.02% males, and mortality was 18.05%. The five top predictors were Respiratory Failure( OR 7.420, 95% CI (1.169-47.103) , Myocardial Infarction (OR 1.639, 95% CI (0.881-3.050), D-dimer (OR 1.493, 95% CI (1.112-2.004), Chronic Kidney Disease (OR 1.493, 95% CI (1.112-2.004), Lymphocyte (OR 1.397, 95% CI ( 1.232-1.584). Conclusions: Comorbidities including chronic kidney disease, myocardial Infarction and DM 1 type; laboratory test results including D-dimer, lymphocyte, neutrophil, creatinine, leukocytes, glucose, hemoglobin; age, SPO2 and respiratory failure were associated with and can predict mortality in COVID-19 patients.


Alnima, T. et al. (2022) ‘COVID-19 Coagulopathy: From Pathogenesis to Treatment.’, Acta haematologica, 145(3), pp. 282–296. Available at:

Awwaliyah, E., Hotimah and Shimabukuro, M. (2022) ‘Clinical characteristics and mortality associated with COVID-19 in islamic hospital of Jemursari, Surabaya, Indonesia: A hospital-based retrospective cohort study’, Bali Medical Journal, 11(3), pp. 1202–1206. Available at:

Bahl, A. et al. (2020) ‘Early predictors of in-hospital mortality in patients with COVID-19 in a large American cohort.’, Internal and emergency medicine, 15(8), pp. 1485–1499. Available at:

Baris Gungor, M.D. a, Adem Atici, M.D. b, Omer Faruk Baycan, M.D. b, Gokhan Alici, M.D. c, Fatih Ozturk, M.D. d, Sevil Tugrul, M.D. e, Ramazan Asoglu, M.D. f, Erdem Cevik, M.D. g, Irfan Sahin, M.D. e, Hasan Ali Barman, M.D. (2020) ‘Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis’, (January).

Barron, E. et al. (2020) ‘Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study’, The Lancet Diabetes and Endocrinology, 8(10), pp. 813–822. Available at:

Berbudi, A. et al. (2020) ‘Type 2 Diabetes and its Impact on the Immune System.’, Current diabetes reviews, 16(5), pp. 442–449. Available at:

Cheng, Y. et al. (2020) ‘Kidney disease is associated with in-hospital death of patients with COVID-19.’, Kidney international, 97(5), pp. 829–838. Available at:

Dong, E., Du, H. and Gardner, L. (2023) ‘An interactive web-based dashboard to track COVID-19 in real time.’, The Lancet. Infectious diseases. United States, pp. 533–534. Available at:

Febrianti, T. et al. (2023) ‘Determinant Factors of Mortality in Pre-elderly and Elderly Patients With COVID-19 in Jakarta, Indonesia.’, Journal of preventive medicine and public health = Yebang Uihakhoe chi, 56(3), pp. 231–237. Available at:

Feldman, E.L. et al. (2020) ‘COVID-19 and Diabetes: A Collision and Collusion of Two Diseases.’, Diabetes, 69(12), pp. 2549–2565. Available at:

Feng, Z. et al. (2020) ‘Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics’, Nature Communications, 11(1), pp. 1–9. Available at:

Geri, G. et al. (2021) ‘Acute kidney injury in SARS-CoV2-related pneumonia ICU patients: a retrospective multicenter study.’, Annals of intensive care, 11(1), p. 86. Available at:

Ghobadi, H. et al. (2022) ‘Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients’, Frontiers in Medicine, 9. Available at:

Herscu, P. et al. (2022) ‘Safety and Evaluation of the Immune Response of Coronavirus Nosode (BiosimCovex) in Healthy Volunteers: A Preliminary Study Extending the Homeopathic Pathogenetic Trial.’, Medicines (Basel, Switzerland), 10(1). Available at:

Huyut, M.T. and Huyut, Z. (2023) ‘Effect of ferritin, INR, and D-dimer immunological parameters levels as predictors of COVID-19 mortality: A strong prediction with the decision trees.’, Heliyon, 9(3), p. e14015. Available at:

Kar, S. et al. (2021) ‘Multivariable mortality risk prediction using machine learning for COVID-19 patients at admission (AICOVID)’, Scientific Reports, 11(1), pp. 1–11. Available at:

Kim, H.R., Jin, H.S. and Eom, Y. Bin (2021) ‘Association between manba gene variants and chronic kidney disease in a korean population’, Journal of Clinical Medicine, 10(11). Available at:

Lewnard, J.A. et al. (2020) ‘Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study.’, BMJ (Clinical research ed.), 369, p. m1923. Available at:

Lippi, G. and Plebani, M. (2020) ‘Laboratory abnormalities in patients with COVID-2019 infection.’, Clinical chemistry and laboratory medicine. Germany, pp. 1131–1134. Available at:

Mesas, A.E. et al. (2020) ‘Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions’, PLoS ONE, 15(11 November), pp. 1–23. Available at:

Narang, J. et al. (2023) ‘Abnormal thrombosis and neutrophil activation increase hospital-acquired sacral pressure injuries and morbidity in COVID-19 patients.’, Frontiers in immunology, 14, p. 1031336. Available at:

Oliveira, E.A. et al. (2021) ‘Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database.’, The Lancet. Child & adolescent health, 5(8), pp. 559–568. Available at:

Palladino, M. (2021) ‘Complete blood count alterations in COVID-19 patients: A narrative review.’, Biochemia medica, 31(3), p. 30501. Available at:

Panda, P.K. et al. (2021) ‘COVID-19 treatment in children: A systematic review and meta-analysis.’, Journal of family medicine and primary care, 10(9), pp. 3292–3302. Available at:

Patiño-Aldana, A.F. et al. (2022) ‘Interaction Effect Between Hemoglobin and Hypoxemia on COVID-19 Mortality: an observational study from Bogotá, Colombia.’, International journal of general medicine, 15, pp. 6965–6976. Available at:

Petrilli, C.M. et al. (2020) ‘Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.’, BMJ (Clinical research ed.), 369, p. m1966. Available at:

Richardson, S. et al. (2020) ‘Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area’, JAMA - Journal of the American Medical Association, 323(20), pp. 2052–2059. Available at:

Setiati, S. et al. (2020) ‘Risk Factors and Laboratory Test Results Associated with Severe Illness and Mortality in COVID-19 Patients: A systematic review’, Acta Medica Indonesiana, 52(3), pp. 227–245.

Simes, J. et al. (2018) ‘D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study.’, Circulation, 138(7), pp. 712–723. Available at:

Sörling, A. et al. (2023) ‘Association Between CKD, Obesity, Cardiometabolic Risk Factors, and Severe COVID-19 Outcomes.’, Kidney international reports, 8(4), pp. 775–784. Available at:


Tezza, F. et al. (2021) ‘Predicting in-hospital mortality of patients with covid-19 using machine learning techniques’, Journal of Personalized Medicine, 11(5). Available at:

Thungthienthong, M. and Vattanavanit, V. (2023) ‘Platelet-to-White Blood Cell Ratio as a Predictor of Mortality in Patients with Severe COVID-19 Pneumonia: A Retrospective Cohort Study’, Infection and Drug Resistance, 16(January), pp. 445–455. Available at:

Tomar, B. et al. (2020) ‘Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.’, Cells, 9(6). Available at:

Usman, E. and Katar, Y. (2023) ‘the Role of Age and Comorbidities on the Outcome of Confirmed Clinically Critical Covid-19 Patients Treated With Remdesivir At Indonesia’S National Referral Hospital’, African Journal of Infectious Diseases, 17(1), pp. 55–59. Available at:

Veras, F.P. et al. (2020) ‘SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology.’, The Journal of experimental medicine, 217(12). Available at:

Weitz, J.I., Fredenburgh, J.C. and Eikelboom, J.W. (2017) ‘A Test in Context: D-Dimer.’, Journal of the American College of Cardiology, 70(19), pp. 2411–2420. Available at:

Xu, J. bo et al. (2020) ‘Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China’, Scientific Reports, 10(1), pp. 1–10. Available at:

Yamada, T. et al. (2020) ‘Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis.’, Clinica chimica acta; international journal of clinical chemistry, 509, pp. 235–243. Available at:

Yu, B. et al. (2020) ‘Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis.’, Journal of thrombosis and thrombolysis, 50(3), pp. 548–557. Available at:

Yuan, M. et al. (2020) ‘Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China’, PLoS ONE, 15(3), pp. 1–10. Available at:

Zhang, Lin et al. (2020) ‘Retrospective analysis of clinical features in 134 coronavirus disease 2019 cases.’, Epidemiology and infection, 148, p. e199. Available at:

Zhu, B. et al. (2021) ‘Correlation between white blood cell count at admission and mortality in COVID-19 patients: a retrospective study.’, BMC infectious diseases, 21(1), p. 574. Available at: